The Flat Glass Market was USD 179.80 billion in 2025 and is projected to reach USD 280.64 billion by 2030, at a CAGR of 9.3% between 2025 and 2030. The market research study includes information on market factors such as the market dynamics, drivers, restraints, challenges, threats, flat glass market growth, opportunities, market trends, development patterns, financial information, latest technologies, innovations, leading competitors, and regional analysis of the market.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=187897592
Float Glass segment is anticipated to be the largest segment in Flat Glass market during the forecasted period in terms of value.
The flat glass market is segmented based on the technology i.e. Float Glass, Rolled Glass and Sheet Glass. The flat glass industry will experience its largest market segment from float glass because of its excellent quality combined with economical production combined with broad implementation within different sectors. Float glass becomes the preferred material for construction and automotive industries and solar applications because its molten production on molten tin surface creates a consistent smooth texture. Float glass controls the majority of the flat glass industry because construction projects use extensive amounts of it for building windows, exterior cladding, partition panels and design elements. Modern architectural designs have increased float glass demand because they embrace energy-efficient buildings and attractive designs. The market expands due to the combination of urban development and infrastructure projects in emerging economies particularly throughout Asia-Pacific and the Middle East.
Construction & Infrastruture end-use Industry accounted for largest share by end use Industry during forecasting period in terms of value.
The flat glass market’s end-use Industry segment consists of construction & Infrastructure, automotive & transportation, solar energy and other end-use Industries. Factors such as fast urbanization and rising smart city expenditures and modern architectural needs drive demand. The increasing number of urbanized areas and rising high-rise building development and commercial construction and residential construction projects drive heavy flat glass usage for windows and facades and partitions throughout buildings. Low-E glass together with insulated glass and smart glass have gained extensive application in sustainable buildings because they assist with energy efficiency while improving visual appeal. The promotion of green building initiatives along with renewable energy activities by governments stimulates flat glass requirement in both developed and emerging countries. Major infrastructure programs like airports and metro stations together with commercial hubs now widely use glass structures because these structures enable better exposure to natural light while reducing energy consumption while creating a contemporary look.
Get a Sample Copy of This Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=187897592
Asia Pacific region is expected to register highest CAGR and also accounts for largest share both in terms of value and volume during forecasted period
The flat glass market by region is divided into Asia-Pacific, North America, Middle East & Africa, Europe and Latin America. Asia Pacific. The Asia-Pacific region represents the market sector for flat glass that grows the fastest because of quick urbanization, growing infrastructure plans, robust industrial demand from construction development, automotive business sectors and renewable energy applications. Several southeastern Asian countries along with China and India experience substantial investments in residential, commercial and transportation infrastructure that generate demand for architectural glass in building components such as windows and facades and partitions. Major countries in the Asia-Pacific automotive sector including China, Japan and India are propelling windshields sunroofs and safety glass demand due to their increasing vehicle production.
Prominent companies include TAIWAN GLASS IND. CORP. (Taiwan), CSG HOLDING CO.,LTD. (China), Fuyao Group (China), Nippon Sheet Glass Co., Ltd (Japan), Saint-Gobain (France), Sisecam (Turkey), Central Glass Co., Ltd. (Japan), AGC Inc. (Japan), Trulite (Georgia), SCHOTT (Germany), Vitro (Mexico), Flat Glass Group Co., Ltd (China), Xinyi Glass Holdings Limited (China), Guardian Industries (US), and Cevital (Algeria) and others.
Nippon Sheet Glass Co., Ltd. (Japan) became an industry leader in flat glass by acquiring Pilkington to boost its global business and product range. The company dedicates its efforts toward both innovation and sustainability by developing cutting-edge glass technologies which include low-emissivity and solar control versions of glass. The success of Nippon Sheet Glass Co., Ltd. (Japan) comes from combining top-notch research capabilities and exceptional quality focus which lets them execute valuable partnerships across construction and automotive sectors. Nippon Sheet Glass Co., Ltd. (Japan) implements vertical and horizontal integration to strengthen its supply chain operations as well as boost market penetration in the changing glass market environment. In October 2022, Nippon Sheet Glass Co., Ltd. (Japan) announced that the second float glass plant based in Los Cardales in the state of Buneos Aires in Argentina has started operations.
Inquire Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=187897592
Saint-Gobain(France) is a French multinational corporation specializing in manufacturing, and distributing materials for contrsution and various other end use Industries. Saint-Gobain(France) operates in over 76 countires and has an extensive portfolio which includes glass, cermaics, plates, and other materials. Saint-Gobain India, a subsidiary of Saint-Gobain(France), inaugurated their new manufacturing plant in Tamil Nadu, India. The new facility Includes, a float glass plant solidifying their flat glass production. Saint-Gobain(France) also expanded its flat glass production in Egypt by 85%, by Introducing second production line.
According to the estimates, the highest contribution in the market size of NSCLC is from the United States followed by Japan, Germany, and the UK.One of the most exciting developments in lung cancer medicine is the introduction of targeted treatments.
The disease epidemiology included in the report provides historical as well as forecasted Non-Small Cell Lung Cancer epidemiology, which is segmented as Total Incident cases of NSCLC patients, Total Incident cases of NSCLC patients by Histology, Total Diagnosed cases of NSCLC patients by Stages, Total NSCLC cases of patients by Genetic mutation/Biomarkers, and Total Treated Cases of NSCLC patients by Line of Therapies scenario of NSCLC in the 7MM.
Click here to know more on Non-Small Cell Lung Cancer pipeline NSCLC report encloses the detailed analysis of Non-Small Cell Lung Cancer marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs.The therapies that are approved for the NSCLC treatment are Rozlytrek (Entrectinib), Imfinzi (Durvalumab), Opdivo (Nivolumab), Tecentriq (Atezolizumab), Keytruda (Pembrolizumab), Tafinlar (Dabrafenib) in combination with Mekinist (Trametinib), Tagrisso (osimertinib), Lorbrena/Lorviqua (Lorlatinib), Vizimpro (Dacomitinib), Alunbrig (Brigatinib), Alecensa (Alectinib), Vitrakvi (Larotrectinib), Portrazza (Necitumumab) along with many more.Drugs covered in the report are:-There are several key players robustly involved in developing potential products such asNazartinib (EGF816)Capmatinib (INC280)Tepmetko (tepotinib)MerestinibJNJ-61186372 (JNJ-6372)Vemurafenib Plus CobimetinibX-396 (Ensartinib)Tedopi (OSE2101)Selpercatinib (LY3527723/ LOXO-292)SAR408701Braftovi (encorafinib) + Mektovi (binimetinib)PADCEV (enfortumab vedotin/ASG-22ME)Pralsetinib (BLU-667)TAK-788: Canakinumab (ACZ885)Avelumab (Bavencio)Veliparib (ABT-888): Sitravatinib (MGCD516)TesevatinibRomiplostim: CabozantinibSym015AMG 510INCMGA00012 (MGA012)Libtayo (Cemiplimab)BavituximabM7824 (Bintrafusp alfa)And many othersKey Players covered in the report are:-Novartis PharmaceuticalsMerck KGaAEli Lilly and CompanyJanssen Research & DevelopmentHoffmann-La RocheXcoveryBeyondSpring PharmaceuticalsOSE ImmunotherapeuticsSanofiPfizerAstellas PharmaSeattle GeneticsBlueprint Medicines CorporationTakedaAbbVieKadmon CorporationAmgenSymphogenRegeneron PharmaceuticalsPeregrine PharmaceuticalsAvid BioservicesGlaxoSmithKlineAnd many othersThe report includes provides in depth analysis historical and forecasted Market Share (%) Distribution of NSCLC, Market Share (%) Distribution of NSCLC by Mutations/Biomarkers, Total Market Size of PD-L1 NSCLC, Total Market Size of BRAF NSCLC, Total Market Size of c-Met, Total Market Size of EGFR, Total Market Size of ALK as well.Market DriverMarket Barrier The reasons for buying this report:The report proffers an overview of pathophysiology, various diagnostic approaches and NSCLC treatment algorithm, including detailed chapters for marketed products and emerging therapies.Historical and forecasted Non-Small Cell Lung Cancer epidemiology in 7MM covering the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2017-2030.Detailed historical and forecasted NSCLC market covering the United States, EU5 and Japan from 2017-2030.Pipeline analysis across different stages of development (Phase III and Phase II), different emerging trends and comparative analysis of pipeline products with comprehensive clinical profiles, key cross-competition, launch date along with product development activities.Detailed Non-Small Cell Lung Cancer market size by therapies, covering the United States, EU5 and Japan from 2017-2030.Reimbursement scenario and Key Opinion Leader Views Table of ContentsKey InsightsExecutive Summary of NSCLCSWOT Analysis of NSCLCNSCLC: Market Overview at a Glance4.1.
Total Market size of NSCLC in JapanALK-Mutation—Market Size21.1.
Report MethodologyDelveInsight CapabilitiesDisclaimerAbout DelveInsight Request a Webex Demo to get a walk-through of the report: https://www.delveinsight.com/sample-request/non-small-cell-lung-cancer-marketRelated Reports:Non-Small Cell Lung Cancer Epidemiology Forecast to 2030Non-Small Cell Lung Cancer Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020Non-Small Cell Lung Cancer Pipeline Insights, 2020About DelveInsightDelveInsight is a premier Business Consulting and Market Research firm, focused exclusively on the life science segment.
Latest Research Report on “Sports Medicine Products Market” Added by Analytical Research Cognizance which covers Market Overview, Future Economic Impact, Competition by Manufacturers, Supply (Production), & Consumption Analysis
This report studies the global market size of Sports Medicine Products Market in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Sports Medicine Products in these regions.
This report also studies the global Sports Medicine Products market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
Get Sample for Sports Medicine Products Market Report @ http://www.arcognizance.com/enquiry-sample/131077
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Market size by End User
The Spirulina Market is expected to grow at a CAGR of 10.3% from 2020-2030, according to a new research report by Next Move Strategy ConsultingSpirulina is a blue green algae with high nutrient content, usually consumed by human & animals.
It is also used as a complementary diet ingredient in aquaculture & poultry feeds owing to the presence of high protein & vitamin content.According to the report, growth in health consciousness among people and the rising demand for dietary supplements are major factors driving the spirulina market growth.
Additionally, high penetration of spirulina in industries such as cosmetics and pharmaceutical owing to the advantageous properties such as anti-aging, anti-wrinkles and othersare bringing changes in market tends.However, low stability & poor sustainability of spirulina derived colours is expected to restrict the market growth.Moreover, growth in research & development activities followed by untapped market opportunities in developing economies are anticipated to provide numerous opportunities to the market players in the coming few years.On the basis of type, spirulina market share is segmented into Arthrospira Platensis and Arthrospira Maxima.
Arthrospira Maxima dominates the global Spirulina market and will be the dominant throughout the forecasted period.On the basis of application, the Spirulina market is categorised into Nutraceuticals, Food & Beverages, Cosmetics, Animal Feed, and Others.Food & Beverages segment is likely to develop significantly over the period of time owing to fast growing food & beverage industry.On the basis of drug formulation, the spirulina market is bifurcated into Powder, Tablet & Capsule, Liquid, and Granule & Gelling Agent.
Powder segment is expected to account for the major market share & dominate the market growth over the forecast period.North America dominates the spirulina market in terms of market size over the forecast period, owing to rising health consciousness among people.
Hansen Holding A/S, Algenol Biofuels Inc., Dongtai City Spirulina Bio-engineering Co., Ltd., Prolgae, Parry Neutraceuticals, Sensient Technologies Corporation, DDW Inc., Algatec and Naturex S.A.Browse key industry insights from the report, “Spirulina Market Size By Type (ArthrospiraPlatensis and Arthrospira Maxima) By Application (Nutraceuticals, Food & Beverages, Cosmetics, Animal Feed, and Others), By Drug Formulation (Powder, Tablet & Capsule, Liquid, and Granule & Gelling Agent)Regional Outlook (U.S., Canada, Germany, UK, France, Spain, Italy, Russia, China, India, Japan, Australia, Indonesia, Malaysia, South Korea, Brazil, Mexico, South Africa, Saudi Arabia, UAE, Kuwait), Growth Potential, Price Trends, Competitive Market Share & Forecast, 2020–2030” in detail along with the table of contents:Key Insights from the Spirulina Market Report:Asia Pacific is the fastest growing region in Spirulina market owing to the rising demand of spirulina from various industries such as cosmetics, food , healthcare and others and government initiatives to promote local spirulina production.The Food & Beverages segment dominates the market in terms of application and is expected to grow at a significant CAGR to maintain the lead till 2030.Some of the major players in the market are DIC Corporation, Cyanotech Corporation, Chr.
